305 related articles for article (PubMed ID: 12439603)
1. Adjuvant immunotherapy for solid tumors: from promise to clinical application.
Mocellin S; Rossi CR; Lise M; Marincola FM
Cancer Immunol Immunother; 2002 Dec; 51(11-12):583-95. PubMed ID: 12439603
[TBL] [Abstract][Full Text] [Related]
2. Systemic specific active immunotherapy for solid tumors. An overview about cancer vaccinetherapy.
Tagliaferri F; Sirovich I; Stipa F; Valente MG; Pupelis G; Tremiterra S
Recenti Prog Med; 1994 Dec; 85(12):591-6. PubMed ID: 7899685
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities of immunotherapy of colorectal cancers and pancreatic tumors].
Klapdor R
Z Gastroenterol Verh; 1991 Mar; 26():220-7. PubMed ID: 1714155
[No Abstract] [Full Text] [Related]
4. Passive, adoptive, and active immunotherapy: a review of clinical trials in cancer.
Mathé G
Cancer Detect Prev Suppl; 1987; 1():279-90. PubMed ID: 3319146
[TBL] [Abstract][Full Text] [Related]
5. New possibilities for cancer therapy with advances in cancer immunology.
MacLean GD; Longenecker BM
Can J Oncol; 1994 Apr; 4(2):249-54. PubMed ID: 7516257
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of renal cell carcinoma.
Graham SD
Semin Urol; 1989 Nov; 7(4):215-27. PubMed ID: 2694258
[TBL] [Abstract][Full Text] [Related]
7. Biologic and immunologic therapy of ovarian cancer.
Bookman MA; Berek JS
Hematol Oncol Clin North Am; 1992 Aug; 6(4):941-65. PubMed ID: 1500395
[TBL] [Abstract][Full Text] [Related]
8. [Rational bases for new approaches to the therapy of pediatric solid tumors: immunotherapy and gene therapy].
Pistoia V; Prigione I; Facchetti P; Corrias MV
Pediatr Med Chir; 1994; 16(3):219-25. PubMed ID: 7971443
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy of tumors: from the first experimental studies to the recent clinical applications. I. Passive immunotherapy].
Burrai I; Di Lallo A
Minerva Med; 1991 Sep; 82(9):519-28. PubMed ID: 1944999
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of lung cancer.
Fishbein GE
Semin Oncol; 1993 Aug; 20(4):351-8. PubMed ID: 8342064
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in cancer immunotherapy.
Reisfeld RA
Clin Lab Med; 1992 Jun; 12(2):201-16. PubMed ID: 1611818
[TBL] [Abstract][Full Text] [Related]
12. [Hypotheses: The adaptation of cancer strategy to progress in tumor immunology. General cancer prevention, metastasis prevention and the combination of classical cancer therapies with O2 multistep immunostimulation].
von Ardenne M
Arch Geschwulstforsch; 1986; 56(6):457-70. PubMed ID: 3548643
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for cancer: an overview.
Proctor JW; Lewis MG; Mansell PW
Can J Surg; 1976 Jan; 19(1):12-9. PubMed ID: 1145
[TBL] [Abstract][Full Text] [Related]
14. [Cancer immunotherapy].
Hurtado Ruano T
Rev Esp Oncol; 1984; 31(2):359-69. PubMed ID: 6545712
[TBL] [Abstract][Full Text] [Related]
15. [Current status of immunotherapy in oncology].
Zielinski C
Acta Med Austriaca; 1991; 18(1):20-4. PubMed ID: 1713730
[TBL] [Abstract][Full Text] [Related]
16. The present status of immunodiagnosis and immunotherapy of cancer.
Pasternak G
Arch Geschwulstforsch; 1981; 51(4):284-93. PubMed ID: 7032448
[TBL] [Abstract][Full Text] [Related]
17. [Immune modulators in the treatment of malignant melanoma].
Weiss J; Voigtländer V
Fortschr Med; 1989 Feb; 107(4):41-2, 45. PubMed ID: 2647601
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer vaccines: Tumor-associated antigens
Wagner S; Mullins CS; Linnebacher M
World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy for colorectal cancer].
Tougeron D; Fauquembergue É; Latouche JB
Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limitations of immunotherapy in the treatment of malignant neoplasms].
Chapuis B; Barrelet L; Dialdas J
Schweiz Med Wochenschr; 1978 Dec; 108(49):1935-8. PubMed ID: 749189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
